Lutetium 177 PSMA (LU-177) radionuclide therapy for men with prostate cancer

The Department of Nuclear Medicine offers the full range of diagnostics and treatment with therapeutic radionuclides. The department has been successful in conducting clinical activities for more than 60 years, and therefore has an extensive experience and outstanding achievements. The department is equipped with the state-of-the-art medical equipment, which allows its specialists to provide the optimal medical services in accordance with the highest international standards. Special focus is on treatment of benign and malignant thyroid diseases.

The Department of Nuclear Medicine offers the full range of diagnostic and therapeutic services in modern nuclear medicine for both outpatients and inpatients. The focus is on the detection and treatment of oncological, neurological and cardiac diseases. The department is the largest institution of this kind in Germany. The international recognition is approved by ISO 9001: 2015 certification.

The Department of Nuclear Medicine at the University Hospital Muenster offers all diagnostic and treatment options in the field of nuclear medicine at the highest medical and technical level. The Department specializes in the treatment of thyroid cancer and different oncological diseases. The Department is headed by Prof. Dr. med. Michael Schäfers.

The Department of Nuclear Medicine offers the full range of services in this field. The key clinical focuses include the diagnosis and treatment of tumors, thyroid, kidney, brain and heart diseases. To do this, doctors have at their disposal all the necessary medical equipment of the latest generation, for example, devices for PET-CT, SPECT/CT, MRI, etc.

The Department of Nuclear Medicine offers the full range of radioisotope diagnostics and treatment of various diseases. The department began its work in 1951 and today it is one of the leading and most reputable medical facilities of this kind in Germany. The clinical activities mainly focus on detection and treatment of pathologies of the thyroid gland, heart, lung cancer, breast cancer, prostate gland, liver cancer and metastases, neuroendocrine tumors, malignant melanoma, and brain tumors. The doctors use only reliable, the most effective innovative methods of examination and therapy, which guarantee an optimal result.

The Department of Nuclear Medicine offers all modern diagnostic and therapeutic procedures using radioactive substances. In addition to the classical methods of nuclear diagnostics, for example, thyroid scintigraphy, special attention is paid to the functional and molecular imaging using the state-of-art PET-CT and SPECT-CT techniques. A special feature of the department is also the Section of Radiochemistry, which produces its own radiopharmaceutical medicines for the targeted therapy of oncopathology (including prostate cancer, neuroendocrine tumors or lymphomas), diseases of the cardiovascular system, and neurological disorders.

The Department of Nuclear Medicine at the University Hospital Erlangen offers the entire spectrum of diagnostic and therapeutic methods in this field. The special innovative focuses include PET/CT, SPECT/CT and innovative therapeutic methods of nuclear medicine, such as peptide radio-receptor therapy for neuroendocrine tumors, radioembolization of liver tumors and prostate cancer treatment with the use of radioligands to the Prostate-Specific-Membrane-Antigen (PSMA).

The Department of Nuclear Medicine at the University Hospital of Halle (Saale) offers not only common and proven types of scintigraphic diagnosis and treatment, due to the use of an effective radiochemotherapy, but also such methods as SPECT/CT and PET/CT with various tracers and current radiopharmaceuticals. The Department is headed by Dr. med. Andreas Odparlik, specialist in nuclear medicine and diagnostic radiology. 

The Department of Nuclear Medicine at the Essen University Hospital performs numerous tasks in the diagnosis and treatment of the entire field of nuclear medicine. With the appropriate recommendations, the Department carries out all radioisotope examinations. A particular attention is given to the diagnosis (and treatment) of thyroid, especially care of patients with thyroid cancer, the diagnosis and treatment of endocrine tumors, as well as myocardial, skeletal scintigraphy and radioisotope examinations in childhood.

The Department of Nuclear Medicine at the University Medical Center Hamburg-Eppendorf offers its patients the entire spectrum of modern radioisotope diagnosis. The peculiarities of the Department include the so-called multimodal methods that involve procedures carried out simultaneously with computer tomography. To carry out PET/CT, the Department has innovative radiopharmaceuticals for the examination of patients with prostate cancer and neuroendocrine tumors.

The Department of Nuclear Medicine and Clinical Imaging Diagnostics offers the full range of radioisotope diagnostics and treatment of various diseases. Both classical diagnostic methods, for example, scintigraphy, SPECT and innovative hybrid techniques, for example, PET-CT, PET-MRT, SPECT-CT are available in the department, which allow to detect metabolic changes at the early stages of various diseases, as well as their localization in the human body. In addition, the department's doctors specialize in radiotherapy for the treatment of oncopathologies.

The Department of Nuclear Medicine offers the entire spectrum of radioisotope diagnosis and radionuclide therapy. In the field of imaging diagnosis, the department is equipped with the state-of-the-art two-chamber systems of single-photon emission computed tomography (SPECT) in its all three units, including a few hybrid SPECT/CT – systems of innovative construction, as well as the advanced PET/CT – (PET: positron emission tomography) systems with the Time-of-Flight function for the highest image quality.

The Department of Nuclear Medicine under the direction of Prof. Dr. med. Felix M. Mottaghy offers all currently available diagnostic and therapeutic methods of nuclear medicine.  All modern therapy types of nuclear medicine are carried out in the nuclear therapy ward with 6 beds. They include radioiodine therapy for the treatment of benign and malignant diseases of thyroid, peptide receptor radionuclide therapy (PRRT), selective internal radiotherapy (SIRT) and radioimmunotherapy. 

The Department of Nuclear Medicine offers the full range of diagnostics and treatment with radioactive substances. It conducts many scintigraphic examinations, ranging from the diagnostics of the thyroid gland and skeleton to amino acid metabolism studies in brain tumors and metabolic studies in other malignant tumors. The department has at its disposal a specialized outpatient clinic for the diagnostics and treatment of thyroid diseases.